Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -154,761 | -115,906 | -96,302 | -33,471 | -185,111 |
| Depreciation Amortization | 33,509 | 25,044 | 18,112 | 8,390 | 24,377 |
| Accounts receivable | -34,654 | -24,422 | -35,231 | -9,660 | 2,468 |
| Accounts payable and accrued liabilities | -8,926 | -16,714 | -13,708 | -4,429 | 9,009 |
| Other Working Capital | -8,852 | -4,020 | -15,920 | -21,386 | 4,591 |
| Other Operating Activity | 80,969 | 69,270 | 71,587 | 21,838 | 66,668 |
| Operating Cash Flow | $-92,715 | $-66,748 | $-71,462 | $-38,718 | $-77,998 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 405,622 | N/A | N/A | N/A | N/A |
| PPE Investments | -22,524 | -16,023 | -11,541 | -4,588 | -17,955 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -30,714 |
| Purchase Of Investment | -502,230 | -296,806 | -157,774 | -33,725 | -234,991 |
| Sale Of Investment | 2,252 | 270,962 | 124,447 | 72,334 | 316,063 |
| Investing Cash Flow | $-116,880 | $-41,867 | $-44,868 | $34,021 | $32,403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 305,906 |
| Debt Repayment | -10,488 | -7,817 | -4,894 | -297 | -73,481 |
| Common Stock Issued | 22,259 | 12,058 | 11,896 | 5,744 | 42,424 |
| Financing Cash Flow | $11,771 | $4,241 | $7,002 | $5,447 | $274,849 |
| Exchange Rate Effect | 311 | 769 | 44 | 5 | -45 |
| Beginning Cash Position | 261,273 | 261,273 | 261,273 | 261,273 | 32,064 |
| End Cash Position | 63,760 | 157,668 | 151,989 | 262,028 | 261,273 |
| Net Cash Flow | $-197,513 | $-103,605 | $-109,284 | $755 | $229,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92,715 | -66,748 | -71,462 | -38,718 | -77,998 |
| Capital Expenditure | -22,524 | -16,023 | -11,541 | -4,588 | -17,955 |
| Free Cash Flow | -115,239 | -82,771 | -83,003 | -43,306 | -95,953 |